Cancer Treatment Centers of America Provide Tailored Treatment Options

Cancer Treatment Centers of America operate with the philosophy that every cancer should have a unique treatment. In today’s world, medicine can be far more precise in treating disease. New and innovative treatments appear frequently. There are thousands of experts in the field of medicine and science working together to bring about positive change in the treatment of cancer.

Cancer Treatment Centers of America treat only cancer. The company addresses and treats all types of cancer. The company also believes in utilizing the very latest in technology along with innovative and effective treatment options, and CTCA’s Website.

Each patient has a dedicated multidisciplinary care unit assigned. Their job of their unit is to offer committed cancer treatment along with therapies that support the patient. These treatments and therapies can help patients manage the negative side effects of cancer treatment. Patients are encouraged to maintain their strength and energy throughout treatments, and more information click here.

When patients arrive at Cancer Treatment Centers, doctors and staff spend quality time to gain a thorough understanding of their needs. Then, a treatment plan is administered under a single roof. This is done so that patients can get the most from their treatments. Finding the right hospital and treatment center is one of the most important things a patient or their family can do when cancer threatens, and

Treating cancer is Cancer Treatment Center’s mission, and they do an excellent job of helping patients through the treatment process. The best that a person can do for his or her self if diagnosed with cancer is to seek the best medical support possible. Cancer Treatment Centers of America provide the services that cancer patients need to get better.

Tempus Looks for a Solution

In previous years there have been many debates and various discussions about electronic health records. In many parts due to government intervention, the healthcare industry drastically improved and is more in step with today’s technology that it has ever been. There is much more that needs to be done before the industry can be considered cutting edge. In the industry, there are still issues in terms of data collection, digital technology and streamlining accessibility of content. The company Tempus, hopes to help with these issues. The company has created a infrastructure that analyzes a patient’s clinical and molecular data. One of the issues the company faced was in the extremely important patient information is collected and stored. Found and stored as physician or progress notes, they are generally free hand notes from the doctors and are therefore not easy to capture and analyze and more information click here.

Tempus combated this issue by developing analytics software, but making it widely available and affordable was still an issue. How This important information was put together and stored was also a complication that needed a solution. These and other issues were solved via software that was created by Tempus, that provided natural language processing and optical character recognition abilities. The co-founder of Tempus, Eric Lefkofsky, first became aware of a need for solutions in the health record field buecasue of a breast cancer diagnosis he wife received. Going through her treatment process he began to see the need for a more consistent means of collecting patient data using digital technology. His Website And With his background in inovation and technogy, including co founding co founding Uptake Technologies and being a founding partner of Lightbank,a venture fund that invests in disruptive technologies, Eric set out to be a part of a solution to the problem. Mr. Lefkofsky and his wife created the Lefkofsky Family Foundation, a privately owned charity, that has a mission statement of providing advancement in progams that directly benefit the community, and also serves as a Trustee of Lurie Children’s Hospital of Chicago. Eric Lefkofsky has long shown a compassion for helping others and improving his community, so being made aware of such an issue, it would be expected that such a person would attempt to find a solution. Tempus continues to work on innovating solutions in the health information arena and learn more about Eric.

More Visit:

Oncotarget: A Peer-review Journal for Scientists

Oncotarget, established in 2010, has provided the scientists and researchers with a platform to publish their research article.

The Journal is a peer-review journal, and that is what makes it unique. Other experienced scientists. Review the different research papers before they are published.

Impact Journals publishes Journal. Experienced and skilled researchers manage the Journal, and that is the reason for the success. The Editors-in-chief are Andrei V. Gudkov and Mikhail Blagosklonny from the Roswell Park Cancer Institute. Download output styles at

Oncotarget is an open Journal and thus means that the public can easily access new content every week. The primary role of the Journal is to help the authors increase the impact and the value of the research.

Two of the members of Editorial Board; Carlo M Croce, the former Editor-in-Chief of Cancer Research and the Andrew Schally, published 27 articles and ten articles respectively.

Since its inception, four of the Oncotarget members win the Breakthrough Prize, which is the highest award.

The Journal is licensed under the Creative Commons Attribution 3.0 license. The Gordon Research Conference is the official sponsors of the Journal. The Journal seeks to promote a life without diseases. The scientists foster research on basic clinical science to help in fighting diseases.

The Journal is focused on the research on cancer and oncology. However, they also publish other health-related research papers including cardiology, metabolism, cell biology, endocrinology, and pharmacology. It is important for researchers to indicate the category of the research paper.

The Journal adheres to strict submission guidelines. They support different type of papers like research papers and editorial news. The paper editorial news should have a minimum of 800 words. The references should also be one page. It is required for scientists to include a maximum of three co-editors.

There is no limit on the number of website and references that can be included. The publishing fee is $ 3.400. As of February 2017, the fee is $2,850. The editorial team also gives discounts like $1,900 to respective research. There are no refunds given once the fist manuscript has been published. Read more about Oncotarget at Google Scholar.